Riken

Such an atlas could enable investigators to understand how genetic variants impact disease risk, define drug toxicities, improve therapies, and advance regenerative medicine.

This Week in Nature

In Nature this week: genomic regions affecting parental care in mice, and more.

A pair of studies also uncovered atrial fibrillation risk loci specific to East Asian populations, particularly near SH3PXD2A.

The FANTOM consortium generated an atlas of nearly 30,000 human long non-coding RNAs that suggests more than 19,000 of them are functional.

The researchers will use single-cell genomics and other approaches to generate information that could ultimately be used to diagnose, monitor, and treat disease.

A team of researchers has characterized the mutations commonly found in liver cancer, and suggests that the disease may be genomically heterogeneous.

Through a genome-wide association study, a team of researchers from Riken uncovered three loci linked to peripheral artery disease susceptibility.

Two new studies appearing in Nature fail to replicate the findings of the discredited STAP papers.

New Strategy at Riken

The new Riken president outlines some of his plans for the institute.

The new Riken president plans to implement changes to prevent research misconduct.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.